Immunizations and Vaccines
Below are links to information related to immunizations and vaccines. Click on the right menu or scroll down to view general information and programs, research, statistics and guidelines on this topic.
CDC Telebriefing on Human Papillomavirus (HPV) Vaccination Coverage and Vaccine Safety Monitoring
CDC hosted a telebriefing to discuss human papillomavirus (HPV) vaccination coverage among adolescent girls and postlicensure vaccine safety monitoring in the United States, 2007–2012.
Human Papillomavirus Vaccination Coverage Among Adolescent Girls, 2007–2012, and Postlicensure Vaccine Safety Monitoring, 2006–2013 — United States
In 2012, only 53.8% of girls had received ≥1 dose of HPV vaccine, and only 33.4% had received all 3 doses of the series. Missed vaccination opportunities remain high. Every health-care visit, whether for back-to-school evaluations or acute problems, should be used to assess teenagers' immunization status and provide recommended vaccines if indicated.
Adults Need Immunizations, Too (6/30/2012)
Your need for immunizations doesn't end when you reach adulthood. Protect yourself and your loved ones from vaccine-preventable diseases. Be the example!
Updated HPV Vaccine (Gardasil®) What You Need to Know (3/30/2012)
This updated information sheet answers eight questions: what is HPV, why get vaccinated, who should get this HPV vaccine and when, why should some people not get the vaccine or wait, what are the risks from this vaccine, what if there is a moderate or severe reaction, what is the national vaccine injury compensation program, and how can I learn more.
Vaccines Help Protect Travelers of All Ages (3/302012)
Travel within the U.S. or to other countries can be an opportunity for volunteerism or work, fun and relaxation, but also exposure to disease. Make sure you and your loved ones are protected against vaccine-preventable diseases that may be only a plane ride away.
Recommended Adult Immunization Schedule - United States, 2012 (3/8/2012)
In October 2011, ACIP approved the adult immunization schedule for 2012, which includes several changes from 2011.
Adult Vaccination Coverage - United States, 2010 (3/8/2012)
Compared with results of the 2009 NHIS survey (1), increases in coverage were observed only for Tdap vaccination for persons aged 19-64 years, zoster vaccination among persons aged ≥60 years, and ≥1 dose HPV vaccination in women aged 19-26 years; coverage for the other vaccines was unchanged at <70%.
Update on Herpes Zoster Vaccine: Licensure for Persons Aged 50 through 59 Years (12/8/2011)
Herpes zoster vaccine (Zostavax, Merck & Co., Inc.) was licensed and recommended in 2006 for prevention of herpes zoster among adults aged 60 years and older (1). In March 2011, the Food and Drug Administration (FDA) approved the use of Zostavax in adults aged 50 through 59 years (2). In June 2011, the Advisory Committee on Immunization Practices (ACIP) declined to recommend the vaccine for adults aged 50 through 59 years and reaffirmed its current recommendation that herpes zoster vaccine be routinely recommended for adults aged 60 years and older.
Updated Recommendations for Use of Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis Vaccine (Tdap) in Pregnant Women and Persons Who Have or Anticipate Having Close Contact with an Infant Aged< 12 Months-Advisory Committee on Immunization Practies (ACIP), 2011 (11/3/2011)
On June 22, 2011, the Advisory Committee on Immunization Practices made recommendations for use of tetanus toxoid, reduced diphtheria toxoid and acellular pertussis (Tdap) in unvaccinated pregnant women and updated recommendations on cocooning and special situations. This report summarizes data considered and conclusions made by ACIP and provides guidance for implementing its recommendations.
Influenza Vaccination Coverage Among Pregnant Women - United States, 2010-11 Influenza Season (9/16/2011)
Results from this survey indicate that the record high influenza vaccination levels among pregnant women reported for the previous influenza season (2009-10) were sustained during the 2010-11 season.
Preteens and Teens Need Vaccines Too! (5/20/2011)
The preteen and teen vaccines not only help protect them, but also their friends, community and family members. There are four vaccines recommended for preteens and teens. All kids should get a flu vaccine every year, and the three other vaccines should be given starting when kids are 11 to 12 years old.
Virus Infection After Sexual Contact with a Military Smallpox Vaccinee
- Washington, 2010 (7/30/10)
This report describes a patient's clinical course and the associated epidemiologic investigation of contact transmission of vaccinia virus from sexual contact.
of the Advisory Committee on Immunization Practices (ACIP), 2010
The 2010 influenza recommendations include new and updated information. Vaccination and health-care providers should be alert to announcements of recommendation updates and should check the CDC influenza website periodically for additional information.
Licensure of Bivalent Human Papillomavirus Vaccine (HPV2, Cervarix) for
Use in Females and Updated HPV Vaccination Recommendations from the Advisory
Committee on Immunization Practices (ACIP) (5/28/10)
In anticipation of FDA licensure of HPV2, ACIP reviewed data on the immunogenicity, efficacy, and safety of HPV2, as well as information on HPV4. At its October 21, 2009, meeting, ACIP approved updated recommendations for use of HPV vaccines in females.
Adult Immunization Schedule - United States, 2010 (2/24/10)
In October 2009, the Advisory Committee on Immunization Practices approved the Adult Immunization Schedule for 2010, which includes several changes. A bivalent human papillomavirus vaccine (HPV2) was licensed for use in females in October 2009. ACIP recommends vaccination of females with either HPV2 or the quadrivalent human papillomavirus vaccine (HPV4). HPV4 was licensed for use in males in October 2009, and ACIP issued a permissive recommendation for use in males. Other changes in publication.
of Yellow Fever Vaccine Virus Through Breast-Feeding - Brazil, 2009 (2/24/10)
This report describes the first laboratory-confirmed case of yellow fever vaccine--associated neurologic disease occurring in an infant secondary to the transmission of yellow fever vaccine virus through breast milk. The infant described in this report also is the youngest reported case of yellow fever vaccine--associated neurologic disease.
Get email updates
To receive email updates about this page, enter your email address:
- Centers for Disease Control and Prevention
1600 Clifton Rd
Atlanta, GA 30333
TTY: (888) 232-6348
- Contact CDC–INFO